NIH-funded research R01 grant

Investigating genetic variants linked to inflammatory bowel diseases

Official title: High throughput functional studies of IBD-associated GWAS variants

Funded at Univ of North Carolina Chapel Hill · NIH-11010791 · Data updated 2026-11-12

This study is looking at how our genes might play a role in inflammatory bowel diseases like Crohn's and ulcerative colitis, so that we can better understand these conditions and find new ways to help patients feel better.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startApril 1, 2023
Project endJanuary 31, 2027
Funding year2025
Award (this year)$655,744
NIH project number5R01DK136262-03
Project IDNIH-11010791 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Crohn's disease or ulcerative colitis.

Less likely to help

Patients with other gastrointestinal disorders unrelated to inflammatory bowel diseases may not benefit from this research.

What this research studies

This research focuses on understanding the genetic factors that contribute to inflammatory bowel diseases (IBD) like Crohn's disease and ulcerative colitis. By analyzing genomic data from patients, the study aims to identify specific genetic variants that affect gene regulation and contribute to the disease's progression. The researchers will use advanced techniques to assess how these variants influence gene activity in relevant tissues, which could lead to better insights into disease mechanisms. Patients may benefit from a deeper understanding of their condition and potential new therapeutic targets.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments and management strategies for patients with inflammatory bowel diseases.

How similar studies have gone: Previous research has shown promise in identifying genetic variants associated with other diseases, suggesting that this approach could yield valuable insights for IBD as well.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Sheikh, Shehzad Z. — Univ of North Carolina Chapel Hill
  • Study coordinator: Sheikh, Shehzad Z.

Related research

Other NIH-funded projects on the same topics.

  • A center for coordinating data related to heart and blood health.

    This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-9732880

  • Healthy work design and worker well-being

    A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11631666

  • Unified and fair multimodal learning for autoimmune diseases

    A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11625649

  • Structural factors linking minimum wage, COVID-19, and community violence

    A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11624218

  • Non-invasive tears biomarker for early Alzheimer's in LMICs

    A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11623923

  • How HPV interacts with our cells' DNA damage system and its effect on cancer

    This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11622604

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.